Modeling now for precision later

GNS Healthcare Inc. is building a platform that aims to make value-based payment models unnecessary by giving companies a way to know which patients will respond before they even launch the drug.

While drug companies and payers are entering conversations about how to structure reimbursement to ensure payers are compensated for treatments that don’t perform as promised, GNS is looking beyond, using machine learning to build models that can dial in the most responsive patient population from the start. ...